Sonoma Pharmaceuticals (SNOA) Balance Sheet: Assets & Liabilities

Sonoma Pharmaceuticals (SNOA) Balance Sheet

As of Mar 31, 2026 (end of fiscal 2026), Sonoma Pharmaceuticals reported total assets of $13.96M and total liabilities of $10.87M. Shareholders' equity was $3.10M, down 29.8% from $4.41M a year earlier. Total debt stood at $691.00K against $2.40M in cash and short-term investments, a net cash position of $1.71M. That puts debt-to-equity at 0.22, compared with 0.06 a year earlier.

Sonoma Pharmaceuticals Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Sonoma Pharmaceuticals, Inc. (SNOA) - Annual data in millions USD
Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Jun 2022	Mar 2022	Jun 2021	Mar 2021	Jun 2020	Jun 2019	Mar 2018	Mar 2017
Current Assets
Cash and Cash Equivalents	2.40	5.37	3.13	3.82	7.40	7.40	4.22	4.22	3.69	3.69	10.07	17.46
Cash & Short-Term Investments	2.40	5.37	3.13	3.82	7.40	7.40	4.22	4.22	3.69	3.69	10.07	17.46
Accounts Receivable	2.53	2.23	2.90	2.57	2.41	2.41	2.81	2.81	3.97	3.48	1.54	2.11
Inventory	3.65	2.92	2.72	2.86	2.66	2.66	2.53	2.53	2.19	3.41	2.87	2.22
Other Current Assets	0.30	2.13	3.80	0.03	3.96	0.62	3.22	3.43	2.53	1.92	1.79	0.85
Total Current Assets	12.10	12.65	12.55	13.80	16.43	16.43	12.77	12.98	12.38	12.50	16.25	22.64
Non-Current Assets
Property, Plant & Equipment (Net)	0.91	0.31	0.65	0.91	0.88	0.88	1.13	1.13	1.33	0.73	1.14	1.24
Other Non-Current Assets	0.06	0.74	1.54	0.07	0.71	0.08	1.08	0.88	0.85	1.23	1.82	1.58
Total Non-Current Assets	1.86	1.05	2.19	2.43	2.42	2.42	2.21	-	2.18	1.95	2.95	2.82
Total Assets	13.96	13.69	14.74	16.23	18.85	18.85	14.99	14.99	14.56	14.45	19.21	25.46
Current Liabilities
Accounts Payable	1.92	0.95	0.61	0.84	1.64	1.64	1.77	1.77	2.07	1.26	1.27	1.26
Short-Term Debt	0.22	0.22	0.32	0.43	1.06	0.81	0.84	0.60	0.62	0.46	0.38	0.20
Current Portion of Long-Term Debt	-	-	-	-	-	0.12	-	-	-	-	-	-
Accrued Liabilities	1.72	2.22	2.11	1.46	-	1.06	-	1.15	-	-	-	-
Deferred Revenue	0.28	0.64	0.48	0.16	1.28	1.28	0.32	0.32	0.27	0.10	0.21	0.52
Other Current Liabilities	0.53	0.49	0.69	0.57	-2.00	0.78	1.15	0.37	1.77	1.77	1.41	0.68
Total Current Liabilities	4.83	4.10	3.72	3.72	5.82	5.82	4.08	4.08	4.73	3.59	3.26	3.29
Non-Current Liabilities
Long-Term Debt	0.47	0.03	0.09	0.16	0.31	0.31	1.84	1.31	0.24	0.01	0.18	0.21
Deferred Tax Liabilities	0.00	0.00	0.00	0.00	0.00	-	0.00	-	0.00	0.00	-0.14	-0.17
Other Non-Current Liabilities	5.56	5.16	4.80	4.38	3.84	4.02	3.48	3.71	3.73	0.00	0.14	0.00
Total Non-Current Liabilities	6.03	5.19	4.88	4.54	4.33	4.33	5.55	5.55	4.21	0.37	0.62	0.74
Total Liabilities	10.87	9.28	8.60	8.25	10.15	10.15	9.62	9.62	8.94	3.96	3.88	4.03
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-200.98	-197.81	-194.35	-189.51	-184.36	-184.36	-179.28	-179.28	-175.33	-169.24	-157.44	-143.10
Accumulated Other Comprehensive Income	-3.24	-4.38	-2.72	-3.42	-4.31	-4.31	-4.58	-4.58	-5.61	-4.35	-3.98	-4.18
Additional Paid-in Capital	207.32	206.59	203.21	200.90	197.37	197.37	189.22	-	186.56	184.07	176.74	168.71
Shares Outstanding	1.80	1.63	0.78	0.25	-	0.16	-	-	-	-	-	-
Total Stockholders' Equity	3.10	4.41	6.14	7.98	8.70	8.70	5.36	5.36	5.62	10.49	15.33	21.43
Total Liabilities & Equity	13.96	13.69	14.74	16.23	18.85	18.85	14.99	-	14.56	14.45	19.21	25.46

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Sonoma Pharmaceuticals Balance Sheet

How much debt does Sonoma Pharmaceuticals have?

Sonoma Pharmaceuticals had total debt of $691.00K as of Mar 31, 2026, against $2.40M in cash and short-term investments. Its debt-to-equity ratio was 0.22. Total debt was $247.00K a year earlier.

What are Sonoma Pharmaceuticals's total assets?

Sonoma Pharmaceuticals reported total assets of $13.96M as of Mar 31, 2026, up 1.9% from $13.69M a year earlier. Total liabilities were $10.87M.

What is Sonoma Pharmaceuticals's shareholders' equity?

Sonoma Pharmaceuticals's shareholders' equity was $3.10M as of Mar 31, 2026, or about $1.72 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition